This site had numerous pages devoted to education, news and treatment of breast cancer. Best known research studies and trials could claim up to 5-10% improvements in reduction of mortality and extension of lives for people with breast cancer. This is true for chemotherapy and radiation treatments for cancer. These therapies are usually advised for people with metastatic cancer or when the malignant cells start to spread to lymph nodes and even distant organs and tissues.

malignant cancerous tumor in a breast

However, one clinical trial (published in “Oncology” journal) achieved something that matches to nothing previously known in cancer treatment. This new therapy involved teaching 60 cancer patients how to breathe less air using reduced breathing exercises. Results? While conventional medical techniques (such as chemotherapy, radiation and surgery) can reduce mortality for this types of cancer by about 10-20% (only for best trials), this study claimed minus 85% in mortality.

The idea of breathing retraining makes total sense since hundreds of studies on cancer claim that hypoxia of cells (or low oxygen levels in tissues) is the key driving factor that controls growth of cancer tumors and their aggressiveness and metastasis.

As a result of this ground-breaking research, previous treatment methods and web pages devoted to them are no longer available. The details and results related to this new breakthrough in breast cancer research can be found in the video and book below.

The only known (translated in English) and detailed sources of information related to this clinical trial and the applied technique (the Buteyko breathing method) are the Amazon book “Doctors Who Cure Cancer” and web pages of

Here are cancer pages from this great site:
Cancer causes
Overbreathing causes low O2 and cancer
Breathing in people with cancer
Terminal stages of cancer
Cancer stages and breath holding 
Cancer treatments and therapies
Carbogen mixture for cancer
Cancer treatment breakthrough
Best breast cancer trial ever

Breast Cancer Mail: Top Clinical Trial